Banque Pictet & Cie Sa Horizon Therapeutics Public LTD CO Transaction History

Banque Pictet & Cie Sa

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$62.39 - $113.8 $404,848 - $738,448	-6,489 Reduced 23.98%	20,571 $0
Q3 2022 Nov 10, 2022	BUY	$58.92 - $84.67 $235,974 - $339,103	4,005 Added 17.37%	27,060 $1.67 Billion
Q2 2022 Aug 08, 2022	SELL	$79.4 - $116.36 $176,188 - $258,202	-2,219 Reduced 8.78%	23,055 $1.84 Million
Q1 2022 May 04, 2022	BUY	$86.42 - $109.81 $84,518 - $107,394	978 Added 4.03%	25,274 $2.66 Million
Q4 2021 Feb 02, 2022	BUY	$98.56 - $119.91 $2.39 Million - $2.91 Million	24,296 New	24,296 $2.62 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.